FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/04/052001 [Registered on: 26/04/2023] Trial Registered Prospectively
Last Modified On: 20/04/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   To find out early hearing loss in patients with a particular autoimmune disease by performing multiple hearing tests  
Scientific Title of Study   Use of behavioural and physiological hearing tests for early detection of asymptomatic sensorineural hearing loss in systemic lupus erythematosus 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR PARVATHI R NAIR 
Designation  Post graduate 
Affiliation  KMC, MANIPAL 
Address  DEPARTMENT OF ENT AND HEAD AND NECK SURGERY, KMC, MANIPAL, UDUPI
ROOM NO. 506, NIH HOSTEL BLOCK A, KMC, MANIPAL, UDUPI
Udupi
KARNATAKA
576104
India 
Phone  7025109794  
Fax    
Email  parvathynair1996@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR KAILESH PUJARY 
Designation  Professor and HOD 
Affiliation  KMC, MANIPAL 
Address  DEPARTMENT OF ENT AND HEAD AND NECK SURGERY, KMC, MANIPAL, UDUPI

Udupi
KARNATAKA
576104
India 
Phone  9845144015  
Fax    
Email  kailesh.pujary@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  DR PARVATHI R NAIR 
Designation  Post graduate 
Affiliation  KMC, MANIPAL 
Address  DEPARTMENT OF ENT AND HEAD AND NECK SURGERY, KMC, MANIPAL, UDUPI
ROOM NO. 506, NIH HOSTEL BLOCK A, KMC, MANIPAL, UDUPI
Udupi
KARNATAKA
576104
India 
Phone  7025109794  
Fax    
Email  parvathynair1996@gmail.com  
 
Source of Monetary or Material Support  
KASTURBA MEDICAL COLLEGE, MANIPAL, UDUPI, KARNATAKA, 576104 
 
Primary Sponsor  
Name  MANIPAL ACADEMY OF HIGHER EDUCATION 
Address  KASTURBA MEDICAL COLLEGE, MANIPAL, UDUPI, KARNATAKA, 576104 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Parvathi R Nair  KASTURBA MEDICAL COLLEGE, MANIPAL,   DEPT OF ENT & HEAD & NECK SURGERY, SPEECH AND AUDIOLOGY, DEPT OF MEDICINE (DIV. OF RHEUMATOLOGY)
Udupi
KARNATAKA 
7025109794

parvathynair1996@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M321||Systemic lupus erythematosus withorgan or system involvement,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  ALL PATIENTS DIAGNOSED WITH SLE AND IS ON TREATMENT. 
 
ExclusionCriteria 
Details  1) OTHER AUTOIMMUNE DISEASES
2) OTHER CAUSES OF HEARING LOSS
3) PRIOR HISTORY OF OTOLOGIC PROCEDURES 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
PREVALENCE OF SENSORINEURAL HEARING LOSS IN PATIENTS WITH SLE USING ADVANCED AUDIOMETRIC ANALYSIS

EFFICIENCY AND CLINICAL USEFULNESS OF AUDIOMETRIC TESTS TO INCORPORATE IT INTO ROUTINE AUDIOLOGIC EXAMINATION 
1-2 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
ASSESS SLE DISEASE ACTIVITY USING PHYSICIAN GLOBAL ASSESSMENT (PGA) SCALE AND CORRELATE WITH OCCURENCE OF HEARING LOSS IN DIFFERENT SEVERITY  1 DAY 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   12/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Otologic manifestations of autoimmune disorders is a rare disease entity. Later the presentation, worse the prognosis in such cases especially since the pathogenesis is unclear.
Systemic lupus erythematosus (SLE) is associated with several comorbidities, including hearing and vestibular disorders
Ear damage in SLE patients has been occasionally reported. However, the frequency and the mechanisms of ear involvement are not well documented.
Andonopoulus et al. in a controlled study showed that 23 out of 40 SLE patients (57.5 per cent) had impaired hearing, which was not associated with the presence of vasculitis, other disease systemic manifestations, or with the presence of anti ds-DNA antibodies. They concluded that these findings are probably attributed to a possible subclinical cochlear hydrops.
In a comparative study, Hearing Loss was found in about one fourth of SLE patients. The majority of patients had a SNHL affecting the middle and mainly the high frequencies. Audiometric tests have shown that more than half of SLE patients have chronic sensorineural hearing impairment, often asymptomatic.

 
Close